Maitri Enterprises (BSE: MAITRI) had a P/E of 37.6× on 6 Nov 2026, above the industry P/E of 27.6×, and the shares are 33% below their 52-week high. It earns ROCE of 20% and ROE of 12%, and sales grew 36% a year over 3 years. Debt is 0.92× equity. It is a small-cap company with a market cap of ₹14 Cr, ranked 6th of 8 Pharmaceutical Retailers companies by market cap; the shares fell 11% over the past year.
- ₹31.20
- ₹31.20
- ₹31.20
- ₹31.10
- 51
Health check
- ReturnsIn line
−11.4% over a year, better than 4 of 7 peers.
- Price tagPricier
P/E 37.6 vs industry 27.6.
- GrowthSteady
Sales +35.8% a year over 3 years.
- ProfitabilityAverage
ROCE 19.9% vs peer median 5.2%.
- Balance sheetFair
Debt 0.92× equity, interest covered 2.3×, Piotroski 7 of 9.
- Red flags3 to check
Quarterly sales down 25.3% on a year ago.
Small cap
Moves with the market
Key metrics
- Market cap
- ₹14 Cr
- Small cap
- P/E
- 37.6
- Industry 27.6
- Price to book
- 2.61
- Peers 3.47
- Dividend yield
- 0.00%
- ROE
- 12.1%
- Peers 8.0%
- ROCE
- 19.9%
- Peers 5.2%
- Debt to equity
- 0.92
- Debt ₹4.83 Cr
- EPS (TTM)
- ₹0.83
- OPM (TTM)
- 5.4%
- Net margin 2.7%
- Sales growth
- −25.3%
- Latest quarter vs a year ago
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 0.44
- EV/EBITDA 10.6
Strengths and risks
Strengths
- Positive operating cash flow in each of the last 4 years.
Risks to check
- Quarterly sales down 25.3% on a year ago.
- 33% below its 52-week high.
- Interest coverage of only 2.6×.
About Maitri Enterprises
Maitri Enterprises Limited primarily engages in the trading of pharmaceutical and medical goods in India. It operates through two segments: Sale of Services and Pharmaceutical Goods. The company also engages in the sale of services by way of a works contract. The company also offers infrastructure, construction, real estate activities, office spaces, residential, retail leasing, and green developments. The company was formerly known as Parth Alluminium…
- Headquarters
- Ahmedabad
- Employees
- 22
- Sector
- Healthcare
- ISIN
- INE501L01024
- Website
- maitrienterprises.com
Price range
- Avg volume (3M)
- 91
- 1-year return
- minus 11.4%
- From 52-week high
- minus 33.0%
Peers · Pharmaceutical Retailers
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDPLUSMedplus Health Services | 604.60 | plus 0.66% | 7,260 | 34.3 | 3.47 | 12.2% | 10.8% | 4.2% | 14.7% | 64.0% | 0.00% | minus 25.7% |
| HEALTHXHealth X Platform | 272.55 | minus 0.42% | 867 | – | 1.35 | −0.2% | 0.2% | −4.4% | 8.0% | – | 0.00% | minus 8.3% |
| ONEGLOBALOne Global Service Provider | 365.45 | minus 7.66% | 714 | 9.7 | 5.06 | 65.7% | 65.3% | 19.2% | 201.8% | 269.3% | 0.23% | minus 32.0% |
| TLLTrident Lifeline | 413.75 | minus 2.07% | 495 | 21.0 | 4.22 | 21.8% | 23.6% | 22.8% | 59.7% | 46.8% | 0.24% | plus 40.8% |
| ACHYUTAchyut Healthcare | 7.76 | plus 4.86% | 187 | 776.0 | 5.45 | 1.1% | 1.0% | 2.2% | 62.6% | 10.9% | 0.00% | plus 28.7% |
| MAITRIMaitri Enterprises | 31.20 | plus 0.32% | 14 | 37.6 | 2.61 | 19.9% | 12.1% | 5.4% | 35.8% | – | 0.00% | minus 11.4% |
| MULLERMuller & Phipps (India) | 193.80 | plus 3.11% | 12 | – | −5.82 | 1.8% | – | −17.2% | 12.9% | – | 0.00% | minus 23.9% |
| DPLDipna Pharmachem | 4.31 | plus 1.65% | 11 | 10.5 | 0.18 | 5.2% | 5.2% | 21.2% | 7.7% | 2.2% | 0.00% | minus 78.4% |
| Median of 7 peers | – | 0.66% | 495 | 21.0 | 3.47 | 5.2% | 8.0% | 4.2% | 14.7% | 46.8% | 0.00% | −23.9% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 7 | 7.8 | 4.7 | 13.9 | 5.2 | |
| 7.7 | 7.5 | 3.8 | 13.1 | 5.5 | |
| −0.7 | 0.3 | 0.9 | 0.8 | −0.3 | |
| −10.1% | 4.0% | 19.1% | 5.7% | −5.4% | |
| 0.1 | 0.3 | 0 | 0 | 0 | |
| 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | |
| 0 | 0 | 0 | 0 | 0 | |
| −0.8 | 0.4 | 0.7 | 0.7 | −0.4 | |
| 15.8% | −5.0% | 38.8% | 30.2% | −20.5% | |
| −0.7 | 0.4 | 0.4 | 0.5 | −0.5 | |
| -1.58 | 0.93 | 0.95 | – | -1.05 |
Profit & loss
- Sales CAGR 3Y
- +35.8%
- ROE
- 12.1%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 13.3 | 19 | 28.7 | 33.3 | |
| – | +43.0% | +50.7% | +16.2% | |
| 12.8 | 18.8 | 27.5 | 31.5 | |
| 0.5 | 0.2 | 1.1 | 1.8 | |
| 3.7% | 1.3% | 4.0% | 5.5% | |
| 0.1 | 0.1 | 1 | −0 | |
| 0.4 | 0.7 | 0.7 | 0.7 | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| 0 | 0 | −1 | −0.1 | |
| 0.2 | −0.4 | 0.3 | 0.9 | |
| 100.6% | −7.8% | 48.8% | 34.7% | |
| −0 | −0.4 | 0.2 | 0.6 | |
| -0.00 | -1.02 | 0.38 | 1.37 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 4.4 | 4.4 | 4.4 | 4.4 | |
| 0.6 | 0.1 | 0.3 | 0.9 | |
| 6.3 | 10.5 | 6.9 | 4.8 | |
| 7.1 | 6.6 | 4.8 | 4.5 | |
| 18.4 | 21.7 | 16.4 | 14.6 | |
| 0.2 | 0.2 | 0.2 | 0.4 | |
| 0.3 | 3.9 | 3.7 | 3.7 | |
| 0.4 | 0.5 | 0.4 | 0.5 | |
| 17.5 | 17 | 12 | 10 | |
| 18.4 | 21.7 | 16.4 | 14.6 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0 | 0.1 | 3 | 3.1 | |
| −0.2 | −3.5 | 1.2 | −0.2 | |
| 0.2 | 3.5 | −4.4 | −2.8 | |
| 0 | 0.1 | −0.1 | 0.1 | |
| −0 | −0.1 | −0.1 | −0.2 | |
| −0 | 0 | 3 | 2.9 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.